EDITAS MEDICINE INC. - COMMON STOCK

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

05 мар 2025 15:05:00 Источник Nasdaq GlobeNewswire

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

24 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

14 янв 2025 08:52:51 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

13 янв 2025 14:37:06 Источник NetDania Notify

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

13 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 дек 2024 08:45:04 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

24 дек 2024 08:49:19 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

23 дек 2024 09:33:49 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

19 дек 2024 08:58:23 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

18 дек 2024 14:10:06 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

16 дек 2024 08:45:55 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

13 дек 2024 08:45:12 Источник NetDania Notify

Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years

12 дек 2024 15:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 дек 2024 11:03:55 Источник NetDania Notify

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

09 дек 2024 11:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

05 дек 2024 09:00:36 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

04 дек 2024 08:46:36 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

03 дек 2024 08:49:45 Источник NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

02 дек 2024 11:56:19 Источник NetDania Notify